Recent days, FDA approved new drug for breast cancer, this breast cancer drug has
generic name kadcyla. Kadcyla working when a breast cancer patient in
the phase of metatesis. So its must be combined with another curing
methode such of chemoterapy. Kadcyla , based on clinical experience
capable to improve live quality of breast cancer patient. Because
kadcyla is very selective drug and only targeting cancer cell, so kadcyla has minor side effect.